Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with NAMS: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
NAMS
NewAmsterdam Pharma Co N.V.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
NAMS
NewAmsterdam Pharma Co N.V.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
LLY, solid
NAMS, dashed
LLY
ELI Lilly & Co
Change
1,371.32
▼
−3.29%
· post 1,359.00
· delayed
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
NAMS
NewAmsterdam Pharma Co N.V.
Change
18.88
▼
−9.79%
· post 19.00
· delayed
After hours
Nov 5 '26
delayed
Mkt cap
$2.5B
Revenue
$19M
Q3 FY26
Revenue
$23M
FY25
vs
Compare
After hours
Nov 5 '26
delayed
LLY
ELI Lilly & Co
vs
NAMS
NewAmsterdam Pharma Co N.V.
1,371.32
▼
−3.29%
post 1,359.00
delayed
Price
18.88
▼
−9.79%
post 19.00
delayed
$1.3T
Mkt cap
$2.5B
Q3 FY26
$24.4B
Revenue
$19M
Q3 FY26
FY25
$65.2B
Revenue
$23M
FY25
Change
Change
LLY
1,371.32
▼
−3.29%
vs
NAMS
18.88
▼
−9.79%
After hours
Nov 5 '26
delayed